Fukoku Mutual Life Insurance CO Biogen Inc. Transaction History

Fukoku Mutual Life Insurance CO

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$222.59 - $267.94 $189,869 - $228,552	853 New	853 $220,000
Q4 2022 Jan 31, 2023	BUY	$252.44 - $306.72 $184,281 - $223,905	730 New	730 $202,000
Q4 2021 Jan 25, 2022	SELL	$223.92 - $287.77 $15,674 - $20,143	-70 Reduced 8.75%	730 $175,000
Q3 2021 Nov 09, 2021	BUY	$282.99 - $369.05 $42,448 - $55,357	150 Added 23.08%	800 $226,000
Q3 2020 Nov 03, 2020	SELL	$264.77 - $305.71 $26,477 - $30,570	-100 Reduced 13.33%	650 $184,000
Q2 2020 Aug 11, 2020	SELL	$258.66 - $342.55 $116,397 - $154,147	-450 Reduced 37.5%	750 $201,000
Q1 2020 May 01, 2020	SELL	$268.85 - $341.04 $53,770 - $68,208	-200 Reduced 14.29%	1,200 $380,000
Q4 2019 Jan 31, 2020	BUY	$220.06 - $304.07 $33,009 - $45,610	150 Added 12.0%	1,400 $415,000
Q1 2018 May 08, 2018	BUY	$260.13 - $367.91 $104,052 - $147,164	400 Added 47.06%	1,250 $342,000
Q3 2017 Nov 14, 2017	BUY	$281.15 - $329.69 $14,057 - $16,484	50 Added 6.25%	850 $266,000
Q2 2017 Aug 14, 2017	BUY	N/A	800	800 $217,000

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Fukoku Mutual Life Insurance CO, based on Form 13F filings with the SEC.

Stay updated on Fukoku Mutual Life Insurance CO with notifications on news.